The Valley Desk

NCT04972942 · Interventional trial

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

Overall registry status Recruiting

Phase 1

Conditions T-Cell Acute Lymphoblastic Lymphoma, T-cell Acute Lymphoblastic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov